Compare Abeona Therapeutics Inc (ABEO) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Rush Street Interactive Inc — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Rush Street Interactive Inc trades at $32.42 (market cap $3.33B). The key difference: Rush Street Interactive Inc is far larger — about 8.9× Abeona Therapeutics Inc's market cap, and Rush Street Interactive Inc is trading nearer its 52-week high, Abeona Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | RSI | |
|---|---|---|
Market Cap | $373.32M | $3.33B |
Sector | Health | Technology |
52-Week High | $7.23 | $32.31 |
52-Week Low | $4.17 | $14.51 |
Enterprise Value | $228.22M | $3.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
RSI trades at $32.22, up 1.7% on the day, with strong technical momentum and bullish moving averages. The company reported Q1 2026 EPS of $0.14, beating estimates, and revenue growth to $1.13B in 2025. Analyst consensus is a Buy with a $29.11 target, though high P/E of 94.76 signals premium valuation. Recent news highlights operational strength and a $100M share repurchase program.
Outlook is positive given earnings beats and sector tailwinds, but risks include elevated valuation and competitive pressures. Net income margin of 2.98% remains thin, requiring sustained growth to justify multiples. Institutional sentiment is bullish, with 10 Buy ratings, supporting near-term upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
